Skip to main content

Advertisement

Log in

CYP2C19 polymorphism increases the risk of endometriosis

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

Estrogen metabolizing gene mutations can be associated with defective hormonal signaling leading to disease processes. Endometriosis is an estrogen dependent that can be influenced by defective signaling in the estrogen pathway.

Objectives

To evaluate the association of A/G 85952 CYP2C19 and A/G 937 HSD17B1 gene polymorphisms with endometriosis through the investigation of a large Brazilian sample of women with endometriosis and a fertile control group.

Methods

Five hundred women with endometriosis and 500 women without endometriosis were tested for CYP2C19 and HSD17B1 polymorphisms, by TaqMan Real Time PCR. The results were statistically analyzed by chi-square, logistic regression and tested for Hardy-Weinberg equilibrium.

Results

The comparison of genotype and allelic frequency of CYP2C19 polymorphism (rs11592737) in patients with endometriosis and control group showed a statistically significant difference (p = 0.0203) and for the HSD17B1 polymorphism (rs605059) differences were not significant (p = 0.0687). Comparing the stages I/II and III/IV endometriosis with the control group for the CYP2C19 we observed p = 0.0133 and p = 0.0564, respectively, and for HSD17B1 the values for p = 0.4319 and p = 0.0667.

Conclusion

We observed that CYP2C19 polymorphism is associated with endometrisis in Brazilian women and can be considered a potential biomarker of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. El-Mahgoub S, Yaseen S. A positive proof for the theory of coelomic metaplasia. Am J Obstet Gynecol. 1980;137:137–40.

    CAS  PubMed  Google Scholar 

  2. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789–99.

    Article  PubMed  Google Scholar 

  3. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81:174–9.

    CAS  PubMed  Google Scholar 

  4. Painter JN, Nyholt DR, Morris A, Zhao ZZ, Henders AK, Lambert A, et al. High-density fine-mapping of a chromosome 10q26 linkage peak suggests association between endometriosis and variants close to CYP2C19. Fertil Steril. 2011;95(7):2236–40.

  5. Baranova H, Bothorishvili R, Canis M, Albuisson E, Perriot S, Glowaczower E, et al. Glutathione S-transferase M1 gene polymorfism and susceptibility to endometriosis in a French population. Mol Hum Reprod. 1997;3:775–80.

    Article  CAS  PubMed  Google Scholar 

  6. Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC. The praline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril. 2002;77(1):43–5.

    Article  PubMed  Google Scholar 

  7. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY. Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod. 2005;20(10):2904–8.

    Article  CAS  PubMed  Google Scholar 

  8. Hsieh YY, Lin CS. P53 codon 11, 72, and 248 gene polymorphism in endometriosis. Int J Biol Sci. 2006;2(4):188–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Lukacik P, Kavanagh KL, Oppermann U. Structure and function of human 17beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol. 2006;248:61–71.

    Article  CAS  PubMed  Google Scholar 

  10. Normand T, Narod S, Labrie F, Simard J. Detection of polymorphisms in the estradiol 17β-hydroxysteroid dehydrogenase 2 gene at the EDH17B2 locus on 17q11–q21. Hum Mol Genet. 1993;2:479–83.

    Article  CAS  PubMed  Google Scholar 

  11. Mannermaa A, Peltoketo H, Winqvist R, Ponder B, Kiviniemi H, Easton D, et al. Human familial and sporadic breast cancer: analysis of the coding regions of the 17β-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay. Hum Genet. 1994;93:319–24.

    Article  CAS  PubMed  Google Scholar 

  12. Revised American Society for Reproductive Medicine classification of endometriosis; 1996, Fertil Steril. 1997; 67(5):817–821.

  13. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19(19):5444.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Bulun SE, Zeitoun KM, Takayama K, Sasano H. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J Mol Endocrinol. 2000;25:35–42.

    Article  CAS  PubMed  Google Scholar 

  15. Bulun SE, Economos K, Miller D, Simpson ER. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab. 1994;79:1831–4.

    CAS  PubMed  Google Scholar 

  16. Trabert B, Schwartz SM, Peters U, De Roos AJ, Chen C, Scholes D, et al. Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes. Fertil Steril. 2011;96(6):1401–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, et al. Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women. Journal of the National Cancer Institute 2004; 96 (12).

  18. Tsuchiya M, Nakao H, Katoh T, Sasaki H, Hiroshima M, Tanaka T, et al. Association between endometriosis and genetics polymorphisms of estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod. 2005;20(4):974–8.

    Article  CAS  PubMed  Google Scholar 

  19. Cayan F, Ayaz L, Aban M, Dilek S, Gümüş LT. Role of CYP2C19 polymorphisms in patients with endometriosis. Gynecol Endocrinol. 2009;25(8):530–5.

    Article  CAS  PubMed  Google Scholar 

  20. Bozdag G, Alp A, Saribas Z, Tuncer S, Aksu T, Gurgan T. CYP17 and CYP2C19 gene polymorphisms in patients with endometriosis. Reprod BioMed Online. 2010;20(2):286–90.

    Article  CAS  PubMed  Google Scholar 

  21. Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer. Cancer Epidemiol Biomark Prev. 2004;13:213–9.

    Article  CAS  Google Scholar 

  22. Martel C, Rheaume J, Takahashi M, Trudel C, Couet J, Luu-The V, et al. Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol. 1992;41:597–60.

    Article  CAS  PubMed  Google Scholar 

  23. Messinger J, Husen B, Koskimies P, Hirvela L, Kallio L, Saarenketo P, et al. Estrone C15 derivatives — a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors. Mol Cell Endocrinol. 2009;1–2(301):216–24.

    Article  Google Scholar 

  24. Bukulmez O, Hardy DB, Carr BR, Auchus RJ, Toloubeydokhti T, Word RA, et al. Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis. J Clin Endocrinol Metab. 2008;93(9):3471–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Santos RP, Encinas F, Lasmar RB, Granjeiro JM, Penna IA. Polimorfismos nos genes MMP2, MMP13, CYP1A1, GSTM1 e EMX2 e endometriose. Femina. 2011;39(6):316.

    Google Scholar 

Download references

Acknowledgments

The authors thank the Brazilian agency Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for scientific initiation scholarship granted by the graduate student Amanda Sonnewend and scientific grant #470333/2013-8.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denise Maria Christofolini.

Additional information

Capsule In a case-control study comprising 500 women with endometriosis and 500 women without the disease we were able to demonstrate a statistically difference considering genotype and allelic frequency of CYP2C19 polymorphism (rs11592737). Comparing endometriosis cases classified as stages I/II and III/IV with control group for the CYP2C19 we observed that the polymorphism is more frequent in the cases with stages I/II. Regarding HSD17B1 polymorphism no association was also found. We concluded that CYP2C19 polymorphism is associated to endometriosis in Brazilian women and can be considered a potential biomarker of the disease.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Christofolini, D.M., Amaro, A., Mafra, F. et al. CYP2C19 polymorphism increases the risk of endometriosis. J Assist Reprod Genet 32, 91–94 (2015). https://doi.org/10.1007/s10815-014-0356-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-014-0356-3

Keywords

Navigation